What is it about?
Replication-deﬁcient adenoviral vectors have been largely employed in experimental and clinical applications for cardiovascular gene therapy. A limiting factor in the use of adenoviral vectors vectors is the relatively low transduction efﬁciency in some cell types, mainly caused by a limited expression of viral attachment and internalization receptors. This study demonstrate that altering adenoviral vector afﬁnity for cellular receptors modulates the level and distribution of transgene activity, conferring characteristics that may allow for treatment customization.
Photo by National Cancer Institute on Unsplash
Read the Original
This page is a summary of: Adenovirus vectors targetingαV integrin or heparan sulfate receptors display different distribution of transgene activity after intramuscular injection, The Journal of Gene Medicine, March 2004, Wiley, DOI: 10.1002/jgm.521.
You can read the full text:
The following have contributed to this page